"Study","Study.year","Analysis.name","Analysis.number","Experimental.cases","Experimental.N","Control.cases","Control.N","Experimental.mean","Experimental.SD","Control.mean","Control.SD","GIV.Mean","GIV.SE","Mean","CI.start","CI.end","Variance","Weight","analysis_key","dataset_name","exp_cases_gt_n","ctrl_cases_gt_n","exp_cases_lt0","ctrl_cases_lt0","exp_n_le0","ctrl_n_le0","exp_cases_nonint","ctrl_cases_nonint","exp_n_nonint","ctrl_n_nonint","double_zero","all_events","sparse_events","exp_sd_le0","ctrl_sd_le0","variance_negative","giv_se_negative","ci_inverted","ci_mismatch"
"Svenningsson 2022",2022,"Disability worsening over 24 months",1,10,98,5,97,0,0,0,0,0,0,2.090909,0.687299,6.36099,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Time to relapse over 24 months",2,0,0,0,0,0,0,0,0,-1.771957,0.633916,0.17,0.049075,0.588897,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Relapse over 24 months",3,3,98,16,97,0,0,0,0,0,0,0.159868,0.044975,0.568268,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Total serious adverse events (SAEs)",4,0,0,0,0,0,0,0,0,-0.150823,0.571426,0.86,0.280608,2.635707,0.0049,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Upper respiratory tract infection ",5,0,0,0,0,0,0,0,0,0.026642,0.135221,1.027,0.787898,1.338662,1.5475857604,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Urinary tract infections ",6,0,0,0,0,0,0,0,0,0.524729,0.472394,1.690001,0.669552,4.265691,0.018284718841,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Skin infections   ",7,0,0,0,0,0,0,0,0,1.187843,1.077361,3.279999,0.397029,27.097237,0.223156091236,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Viral infections     ",8,0,0,0,0,0,0,0,0,1.568616,1.489187,4.8,0.259205,88.887265,1.160706724321,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Annualised relapse rate",9,0,98,0,97,0.015,0.108984,0.087,0.218314,0,0,-0.072,-0.120509,-0.023491,0,100,"9::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"T2 or gadolinium MRI lesions over 24 months",10,21,98,36,97,0,0,0,0,0,0,0.462121,0.245035,0.871533,0,100,"10::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Treatment discontinuation due to adverse events",11,3,98,16,90,0,0,0,0,0,1.44366934014059,0.146053,0.041016,0.520077,2.08418116366197,100,"11::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Svenningsson 2022",2022,"Any adverse event",12,0,0,0,0,0,0,0,0,-0.34249,0.07,0.71,0.618977,0.814409,0,100,"12::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Time to relapse over 24 months ",1,0,120,0,17,0,0,0,0,-1.3471,0.955,0.259993,0.04,1.689894,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Time to relapse over 24 months ",1,0,120,0,50,0,0,0,0,-1.4271,0.7281,0.240004,0.057605,0.99995,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Time to relapse over 24 months ",1,0,120,0,215,0,0,0,0,-1.9661,0.5253,0.140002,0.050003,0.391985,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Time to relapse over 24 months ",1,0,120,0,86,0,0,0,0,-1.2379,0.6316,0.289993,0.084095,1.000013,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Serious adverse events assessed with Grades 3/4 CTCAE over 24 months ",2,4,120,0,17,0,0,0,0,0,0,1.351931,0.069732,26.21074,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Serious adverse events assessed with Grades 3/4 CTCAE over 24 months ",2,4,120,4,50,0,0,0,0,0,0,0.396552,0.095149,1.652701,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Serious adverse events assessed with Grades 3/4 CTCAE over 24 months ",2,4,120,8,215,0,0,0,0,0,0,0.892241,0.263005,3.026922,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Serious adverse events assessed with Grades 3/4 CTCAE over 24 months ",2,4,120,1,86,0,0,0,0,0,0,2.931034,0.321825,26.694506,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Gadolinium magnetic resonance imaging (MRI) lesions ",3,0,104,0,43,0,0,0,0,-2.1203,1.135,0.119996,0.012973,1.109888,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Gadolinium magnetic resonance imaging (MRI) lesions ",3,0,104,0,15,0,0,0,0,-1.1087,1.7405,0.329988,0.010889,10.000322,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Gadolinium magnetic resonance imaging (MRI) lesions ",3,0,104,0,159,0,0,0,0,-2.3026,0.7442,0.099999,0.023256,0.429989,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Gadolinium magnetic resonance imaging (MRI) lesions ",3,0,104,0,73,0,0,0,0,-2.1203,0.8126,0.119996,0.024405,0.59,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Treatment discontinuation due to adverse events",4,1,120,12,86,0,0,0,0,0,0,0.051821,0.006601,0.406798,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Treatment discontinuation due to adverse events",4,1,120,3,17,0,0,0,0,0,0,0.039216,0.003816,0.403032,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Treatment discontinuation due to adverse events",4,1,120,2,50,0,0,0,0,0,0,0.201681,0.017867,2.276564,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Granqvist 2018",2018,"Treatment discontinuation due to adverse events",4,1,120,60,215,0,0,0,0,0,0,0.021709,0.002966,0.158908,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Disability worsening over 24 months ",1,0,292,0,147,0,0,0,0,-0.3484,0.2315,0.705816,0.448372,1.111079,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Relapse over 24 months ",2,0,292,0,147,0,0,0,0,-0.5178,0.6142,0.59583,0.178778,1.985776,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Serious adverse events over 24 months ",3,0,292,0,147,0,0,0,0,0.2225,0.2878,1.249196,0.710648,2.195868,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Common infections over 24 months ",4,0,292,0,147,0,0,0,0,0.1282,0.214,1.13678,0.747342,1.729154,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Cancer over 24 months ",5,0,292,0,147,0,0,0,0,-0.6931,1.0052,0.500024,0.069721,3.586066,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Mortality over 24 months ",6,0,292,0,147,0,0,0,0,-1.3897,1.229,0.24915,0.022404,2.770688,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Treatment discontinuation due to adverse events",7,9,292,1,147,0,0,0,0,0,0,4.64311,0.582614,37.00297,0,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"First infusion reactions",8,196,292,34,147,0,0,0,0,0,0,6.785539,4.307113,10.690117,0,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hawker 2009",2009,"Second infusion reactions",9,66,292,22,147,0,0,0,0,0,0,1.659292,0.976995,2.81808,0,100,"9::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Relapse over 12 months",1,0,69,0,35,0,0,0,0,-0.9628,0.4568,0.381822,0.155967,0.934739,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Serious adverse events (SAEs)",2,0,69,0,35,0,0,0,0,-0.1054,0.6009,0.899964,0.277165,2.922216,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Komori 2016",2016,"Common infections",3,0,18,0,9,0,0,0,0,-0.9163,0.8515,0.399996,0.07538,2.122531,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Common infections",3,0,69,0,35,0,0,0,0,-0.0896,0.4566,0.914297,0.373619,2.237411,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Cancer",4,0,69,0,35,0,0,0,0,0.4413,1.646,1.554727,0.061741,39.150012,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Mortality",5,0,69,0,35,0,0,0,0,0.4413,1.646,1.554727,0.061741,39.150012,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Annualised relapse rate ",6,0,69,0,35,0.4,0.81,0.7,1.05,0,0,-0.3,-0.696905,0.096905,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Gadolinium MRI lesions over 12 months",7,0,66,0,35,0,0,0,0,-1.5509,0.4827,0.212057,0.082334,0.54617,0,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Treatment discontinuation due to adverse events",8,3,69,2,35,0,0,0,0,0,0,0.75,0.11943,4.709871,0,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Komori 2016",2016,"Treatment discontinuation due to adverse events",8,1,18,0,9,0,0,0,0,0,0,1.628571,0.06027,44.006297,0,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Cardiovascular events",9,1,69,0,35,0,0,0,0,0,0,1.554745,0.061738,39.153207,0,100,"9::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"First infusion reactions",10,54,69,14,35,0,0,0,0,0,0,5.4,2.226987,13.093924,0,100,"10::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hauser 2008",2008,"Second infusion reactions",11,14,69,14,35,0,0,0,0,0,0,0.381818,0.155968,0.934712,0,100,"11::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kalincik 2019",2019,"Time to disability worsening over 24 months' follow-up",1,0,127,0,838,0,0,0,0,0.955511,0.737818,2.599999,0.612268,11.040913,0.543919525081,26.574336,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Rollot 2022",2022,"Time to disability worsening over 24 months' follow-up",1,0,278,0,403,0,0,0,0,-0.076989,0.211929,0.9259,0.611181,1.402679,0.044913901041,73.425664,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Spelman 2018",2018,"Time to disability worsening over 24 months' follow-up",1,0,321,0,532,0,0,0,0,-0.1508,0.2567,0.86002,0.520002,1.422368,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kalincik 2019",2019,"Time to disability worsening over 24 months' follow-up",1,0,131,0,103,0,0,0,0,-2.120264,1.408307,0.12,0.007593,1.896418,1.982610434704,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Roos 2023",2023,"Time to disability worsening over 24 months' follow-up",1,0,186,0,710,0,0,0,0,0.41211,0.286128,1.510001,0.861836,2.645634,0.081869232384,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2016",2016,"Time to relapse over 18 to 24 months' follow-up",2,0,69,0,95,0,0,0,0,-2.5257,0.7073,0.080002,0.020001,0.320005,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Spelman 2018",2018,"Time to relapse over 18 to 24 months' follow-up",2,0,461,0,922,0,0,0,0,-1.7148,0.511,0.18,0.066116,0.490045,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Time to relapse over 18 to 24 months' follow-up",2,0,48,0,105,0,0,0,0,0.00995,0.178617,1.01,0.711676,1.433377,0.67436944,16.264758,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kalincik 2019",2019,"Time to relapse over 18 to 24 months' follow-up",2,0,946,0,142,0,0,0,0,-0.072571,0.087698,0.93,0.783131,1.104413,0.007690939204,67.470483,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Rollot 2022",2022,"Time to relapse over 18 to 24 months' follow-up",2,0,278,0,403,0,0,0,0,0.00995,0.178617,1.01,0.711676,1.433377,0.031904032689,16.264758,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kalincik 2019",2019,"Time to relapse over 18 to 24 months' follow-up",2,0,131,0,103,0,0,0,0,0.530628,0.276769,1.7,0.98824,2.924388,0.076601079361,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2016",2016,"Serious adverse events assessed with Grades 3/4 CTCAE over 18 to 24 months' follow-up",3,1,114,3,142,0,0,0,0,0,0,0.410029,0.042076,3.995708,0,63.206223,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Serious adverse events assessed with Grades 3/4 CTCAE over 18 to 24 months' follow-up",3,0,48,3,88,0,0,0,0,0,0,0.251841,0.01274,4.978368,0,36.793777,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Serious adverse events assessed with Grades 3/4 CTCAE over 18 to 24 months' follow-up",3,0,48,4,105,0,0,0,0,0,0,0.232532,0.012272,4.406035,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2016",2016,"Common infections over 18 to 72 months' follow-up",4,0,114,0,142,0,0,0,0,-1.066,0.8119,0.344383,0.070138,1.690957,0,4.569354,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Common infections over 18 to 72 months' follow-up",4,0,48,0,88,0,0,0,0,0.636,0.8371,1.88891,0.36616,9.744333,0,4.298384,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Luna 2020",2020,"Common infections over 18 to 72 months' follow-up",4,0,3260,0,1535,0,0,0,0,0.279,0.1818,1.321807,0.925592,1.887629,0,91.132262,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Evertsson 2020",2020,"Common infections over 18 to 72 months' follow-up",4,0,311,0,161,0,0,0,0,-3.7653,1.4509,0.023161,0.001348,0.397887,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Luna 2020",2020,"Common infections over 18 to 72 months' follow-up",4,0,3260,0,2217,0,0,0,0,0.5342,0.218,1.706083,1.112854,2.615544,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Common infections over 18 to 72 months' follow-up",4,0,48,0,105,0,0,0,0,1.2335,0.9302,3.433225,0.554517,21.25641,0,4.418561,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Luna 2020",2020,"Common infections over 18 to 72 months' follow-up",4,0,3260,0,1588,0,0,0,0,0.4233,0.2,1.526992,1.031802,2.259837,0,95.581439,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2020",2020,"Time to cancer over 24 to 36 months' follow-up",5,0,0,0,0,0,0,0,0,-0.510826,0.270355,0.6,0.353203,1.019243,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2020",2020,"Time to cancer over 24 to 36 months' follow-up",5,0,0,0,0,0,0,0,0,-0.314711,0.28228,0.73,0.419803,1.269404,0.0796819983999999,17.737131,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Rollot 2022",2022,"Time to cancer over 24 to 36 months' follow-up",5,0,0,0,0,0,0,0,0,-0.223144,0.131075,0.8,0.618755,1.034335,0.017180655625,82.262869,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Mortality over 24 months' follow-up",6,1,48,0,88,0,0,0,0,0,0,5.589474,0.223336,139.889008,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Mortality over 24 months' follow-up",6,1,48,0,105,0,0,0,0,0,0,6.663158,0.266526,166.579293,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cuijpers 2019",2019,"Time to mortality over 24 months' follow-up",7,0,0,0,0,0,0,0,0,-0.524249,1.233347,0.592,0.052783,6.639699,0.0796819983999999,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Spelman 2018",2018,"Annualised relapse rate (change from baseline) - by type of DMT",8,0,461,0,922,0.004,0.0656,0.022,0.0774,0,0,-0.018,-0.025799,-0.010201,0,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"Roos 2023",2023,"Annualised relapse rate (end point) - by type of DMT",9,0,0,0,0,0,0,0,0,0.587787,0.137502,1.800001,1.374772,2.356756,0,100,"9::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"MRI gadolinium-enhancing lesions over 18 to 24 months' follow-up",10,0,43,0,95,0,0,0,0,0,0.8212,1,0.199983,5.000423,0,100,"10::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2016",2016,"MRI gadolinium-enhancing lesions over 18 to 24 months' follow-up",10,0,69,0,95,0,0,0,0,-2.5257,0.7073,0.080002,0.020001,0.320005,0,71.749589,"10::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"MRI gadolinium-enhancing lesions over 18 to 24 months' follow-up",10,0,43,0,81,0,0,0,0,-2.0225,1.1272,0.132324,0.014527,1.205352,0,28.250411,"10::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2016",2016,"MRI gadolinium-enhancing lesions or new T2 lesions over 12 to 24 months' follow-up",11,0,75,0,107,0,0,0,0,-4.6052,0.9142,0.01,0.001667,0.060001,0.83576164,100,"11::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Nygaard 2022",2022,"MRI gadolinium-enhancing lesions or new T2 lesions over 12 to 24 months' follow-up",11,0,40,0,33,0,0,0,0,-1.568616,0.527705,0.208333,0.074059,0.58606,0.278472567025,100,"11::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Rollot 2022",2022,"MRI gadolinium-enhancing lesions or new T2 lesions over 12 to 24 months' follow-up",11,0,187,0,263,0,0,0,0,0.620576,0.338602,1.859999,0.957843,3.611863,0.114651314404,100,"11::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Evertsson 2020",2020,"Treatment discontinuation due to adverse events  over 12 to 24 months' follow-up - by type of DMT",12,8,311,15,161,0,0,0,0,0,0,0.256986,0.106541,0.619873,0,100,"12::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Treatment discontinuation due to adverse events  over 12 to 24 months' follow-up - by type of DMT",12,0,48,6,88,0,0,0,0,0,0,0.130849,0.007213,2.373831,0,100,"12::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Treatment discontinuation due to adverse events  over 12 to 24 months' follow-up - by type of DMT",12,0,48,3,105,0,0,0,0,0,0,0.301915,0.015292,5.96077,0,100,"12::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Cardiovascular events over 18 to 24 months' follow-up - by type of DMT",13,0,48,0,105,0,0,0,0,0,0,NA,NA,NA,0,NA,"13::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Alping 2016",2016,"Cardiovascular events over 18 to 24 months' follow-up - by type of DMT",13,1,114,5,142,0,0,0,0,0,0,0.242478,0.027924,2.105571,0,68.935083,"13::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Boremalm 2019",2019,"Cardiovascular events over 18 to 24 months' follow-up - by type of DMT",13,0,48,1,88,0,0,0,0,0,0,0.601375,0.024033,15.047998,0,31.064917,"13::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cuijpers 2019",2019,"Time to cardiovascular events over 24 months' follow-up",14,0,3260,0,1535,0,0,0,0,0.71344,0.979658,2.041,0.299197,13.922892,0.672506604225,100,"14::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cuijpers 2019",2019,"Time to cardiovascular events over 24 months' follow-up",14,0,3260,0,1588,0,0,0,0,-0.667479,0.820065,0.513,0.10282,2.559518,0.704654476969,100,"14::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cuijpers 2019",2019,"Time to cardiovascular events over 24 months' follow-up",14,0,3260,0,2046,0,0,0,0,-0.683197,0.839437,0.505,0.097445,2.617106,1.521144822409,100,"14::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Longinetti 2022",2022,"Time to depression or antidepressant use over 96 months' follow-up",15,0,0,0,0,0,0,0,0,-0.328504,0.146779,0.72,0.54,0.96,0.017180655625,100,"15::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Longinetti 2022",2022,"Time to depression or antidepressant use over 96 months' follow-up",15,0,0,0,0,0,0,0,0,-0.174353,0.168178,0.84,0.604124,1.167973,0.0282838396839999,100,"15::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Longinetti 2022",2022,"Time to depression or antidepressant use over 96 months' follow-up",15,0,0,0,0,0,0,0,0,-0.287682,0.147916,0.75,0.561248,1.002231,0.045934348329,100,"15::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Longinetti 2022",2022,"Time to depression or antidepressant use over 96 months' follow-up",15,0,0,0,0,0,0,0,0,-0.094311,0.214323,0.91,0.597873,1.385075,0.045222999649,100,"15::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Longinetti 2022",2022,"Time to depression or antidepressant use over 96 months' follow-up",15,0,0,0,0,0,0,0,0,-0.051293,0.212657,0.95,0.626195,1.441245,0.0282838396839999,100,"15::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Evertsson 2020",2020,"First infusion reactions",16,2,311,2,161,0,0,0,0,0,0,0.514563,0.071811,3.687098,0,100,"16::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Komori 2016",2016,"Serious adverse events",1,4,18,4,9,0,0,0,0,0,0,0.357143,0.063859,1.997381,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Komori 2016",2016,"Cancer",2,1,18,1,9,0,0,0,0,0,0,0.470588,0.025987,8.52171,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Komori 2016",2016,"Cardiovascular events",3,1,18,1,9,0,0,0,0,0,0,0.470588,0.025987,8.52171,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Serious adverse events ",1,0,43,0,41,0,0,0,0,0,0,NA,NA,NA,0,NA,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Etemadifar 2019",2019,"Common infections - by different DMTs",2,9,39,13,30,0,0,0,0,0,0,0.392308,0.139014,1.107118,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Common infections - by different DMTs",2,3,43,1,41,0,0,0,0,0,0,3,0.299212,30.079013,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Annualised relapse rate",3,0,43,0,41,0.56,0.73,0.37,0.58,0,0,0.19,-0.091293,0.471293,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Gadolinium MRI lesions ",4,3,43,4,41,0,0,0,0,0,0,0.69375,0.14545,3.308959,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Treatment discontinuation due to adverse events ",5,2,43,2,41,0,0,0,0,0,0,0.95122,0.127657,7.08787,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cheshmavar 2021",2021,"Opportunistic infections",6,0,43,0,41,0,0,0,0,0,0,NA,NA,NA,0,NA,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Naegelin 2019",2019,"Time to disability worsening over 36 months' follow-up",1,0,44,0,44,0,0,0,0,-0.7133,0.3269,0.490024,0.258202,0.929984,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alcala 2022",2022,"Time to disability worsening over 18 months' follow-up",1,0,49,0,95,0,0,0,0,-0.0969,0.1912,0.907647,0.623975,1.320282,0.03655744,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alcala 2022",2022,"Treatment discontinuation due to adverse events",2,0,49,0,46,0,0,0,0,0,0,NA,NA,NA,0,NA,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Vollmer 2020a",2020,"Relapse over 24 months - by type of DMT (unadjusted data)",1,6,182,24,271,0,0,0,0,0,0,0.350852,0.140487,0.876218,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Relapse over 24 months - by type of DMT (unadjusted data)",1,6,182,44,342,0,0,0,0,0,0,0.230888,0.096434,0.552809,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Relapse over 24 months - by type of DMT (unadjusted data)",1,6,182,27,451,0,0,0,0,0,0,0.535354,0.217247,1.319248,0,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Common infections - by type of DMT",2,0,182,0,342,0,0,0,0,0.87,0.6772,2.386911,0.632998,9.000567,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Common infections - by type of DMT",2,0,182,0,451,0,0,0,0,1.4395,0.7357,4.218586,0.997557,17.840042,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Common infections - by type of DMT",2,0,182,0,272,0,0,0,0,0.0616,0.5776,1.063537,0.342846,3.299184,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2020",2020,"Cancer - by type of DMT",3,0,4187,0,1620,0,0,0,0,-0.5162,0.2781,0.596784,0.346017,1.029287,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Alping 2020",2020,"Cancer - by type of DMT",3,0,4187,0,1670,0,0,0,0,-0.304,0.2919,0.737861,0.416398,1.307496,0,100,"3::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"T2 MRI lesions - by DMT (unadjusted data)",4,32,182,95,271,0,0,0,0,0,0,0.395228,0.250506,0.623559,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"T2 MRI lesions - by DMT (unadjusted data)",4,32,182,108,342,0,0,0,0,0,0,0.462222,0.296331,0.720982,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"T2 MRI lesions - by DMT (unadjusted data)",4,32,182,114,451,0,0,0,0,0,0,0.630643,0.407479,0.976028,0,100,"4::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Gadolinium MRI lesions (unadjusted data)",5,1,182,36,271,0,0,0,0,0,0,0.036065,0.004898,0.265537,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Gadolinium MRI lesions (unadjusted data)",5,1,182,26,451,0,0,0,0,0,0,0.09031,0.012163,0.670559,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Gadolinium MRI lesions (unadjusted data)",5,1,182,34,342,0,0,0,0,0,0,0.050049,0.006793,0.368717,0,100,"5::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Discontinuation due to adverse events - by type of DMT",6,0,182,0,271,0,0,0,0,-1.273,0.3915,0.27999,0.129986,0.603099,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Discontinuation due to adverse events - by type of DMT",6,0,182,0,342,0,0,0,0,-1.204,0.3537,0.299992,0.149982,0.600039,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Discontinuation due to adverse events - by type of DMT",6,0,182,0,451,0,0,0,0,0.0953,0.4231,1.099989,0.480004,2.520761,0,100,"6::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Cardiovascular events - by DMT",7,0,170,0,271,0,0,0,0,-1.8149,1.4938,0.162854,0.008715,3.043153,0,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Cardiovascular events - by DMT",7,0,182,0,451,0,0,0,0,-0.195,1.6353,0.822835,0.033369,20.290019,0,100,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Vollmer 2020a",2020,"Cardiovascular events - by DMT",7,0,181,0,342,0,0,0,0,0,0,NA,NA,NA,0,NA,"7::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Moss 2020",2020,"First infusion reaction",8,14,67,12,67,0,0,0,0,0,0.389424970067643,1.210692,0.513143,2.856462,0.151651807312185,100,"8::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Hou 2021",2021,"Relapse over 24 months",1,0,0,0,0,0,0,0,0,-0.102,0.035,0.90303,0.84316,0.96715,0.001225,100,"1::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
"Hou 2021",2021,"Difference in two-year relapse rate",2,0,0,0,0,0,0,0,0,-2.025,0.377,-2.025,-2.763906,-1.286094,0,100,"2::overall","CD013874_pub3_data",FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE
